Fibrin Sealants

Fibrin Sealants

Global Fibrin Sealants Market to Reach US$1.6 Billion by 2030

The global market for Fibrin Sealants estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Liquid Sealants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Patches segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$281.8 Million While China is Forecast to Grow at 8.9% CAGR

The Fibrin Sealants market in the U.S. is estimated at US$281.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$364.1 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Fibrin Sealants Market – Key Trends & Drivers Summarized

What Are Fibrin Sealants, And Why Are They Essential in Medical Applications?

Fibrin sealants are a type of biological adhesive used in various medical applications to promote wound healing and tissue repair. Composed of fibrinogen and thrombin, these sealants mimic the final stages of the blood coagulation process, facilitating the formation of a fibrin clot that effectively seals wounds and enhances hemostasis. Fibrin sealants are used in a wide range of surgical procedures, including general surgery, orthopedics, neurosurgery, and cardiovascular surgery. Their ability to adhere to tissue surfaces, control bleeding, and accelerate healing makes them a valuable tool for surgeons and healthcare professionals.

The significance of fibrin sealants in medical practice extends beyond their adhesive properties. They provide a minimally invasive solution for managing bleeding and promoting tissue healing, reducing the need for traditional sutures and staples in certain procedures. Additionally, fibrin sealants can deliver therapeutic agents, such as antibiotics or growth factors, directly to the wound site, further enhancing their effectiveness. As the demand for advanced wound care and surgical solutions continues to rise, the role of fibrin sealants in improving patient outcomes and surgical efficiency is increasingly recognized.

What Are the Main Applications of Fibrin Sealants, And How Do They Cater to Healthcare Needs?

Fibrin sealants have a wide range of applications across various medical fields, catering to the specific needs of healthcare providers and patients. In general surgery, fibrin sealants are commonly used to control bleeding during procedures such as liver resections, gastric surgeries, and colorectal surgeries. Their ability to provide rapid hemostasis helps reduce blood loss and the risk of complications, ultimately improving surgical outcomes. The use of fibrin sealants in these applications also enhances recovery times and minimizes postoperative pain, benefiting both patients and healthcare facilities.

In orthopedic surgery, fibrin sealants are employed to support tissue healing and reduce the risk of complications following procedures such as joint replacements, ligament repairs, and fracture fixations. By promoting the adhesion of tissues and enhancing the healing process, fibrin sealants contribute to faster recovery and improved functional outcomes for patients. Their application in managing musculoskeletal injuries is becoming increasingly common as surgeons seek effective solutions to optimize surgical results.

Neurosurgery is another area where fibrin sealants are gaining traction. They are used to manage bleeding during cranial and spinal procedures, where controlling hemorrhage is critical. The biocompatibility and adhesive properties of fibrin sealants make them ideal for use in delicate surgical environments, ensuring that bleeding is effectively managed without compromising surrounding tissues. As advancements in neurosurgical techniques continue, the adoption of fibrin sealants is expected to increase.

Fibrin sealants are also used in cardiovascular surgery, particularly in procedures involving cardiac bypass and valve replacement. They provide effective hemostasis in areas where traditional sutures may be challenging to apply, enhancing surgical precision and reducing the risk of postoperative bleeding. The growing demand for minimally invasive cardiovascular procedures is further driving the need for innovative solutions like fibrin sealants that promote effective wound closure and healing.

Furthermore, fibrin sealants are being explored in emerging applications, such as wound care and tissue engineering. Their use in chronic wound management is gaining attention, as they can enhance healing in difficult-to-treat wounds by providing a supportive environment for tissue regeneration. As research continues to uncover new applications, the potential for fibrin sealants in the healthcare industry will likely expand, catering to a broader range of medical needs.

How Are Technological Advancements Impacting the Fibrin Sealants Market?

Technological advancements are significantly influencing the fibrin sealants market by improving product formulations, enhancing application techniques, and expanding their clinical use. One notable development is the innovation in fibrin sealant formulations, which aim to enhance their performance and usability. Manufacturers are focusing on creating fibrin sealants with optimized viscosity and flow characteristics, enabling easier application and improved adhesion to tissue surfaces. These advancements make fibrin sealants more user-friendly for surgeons, contributing to their growing adoption in various surgical procedures.

Additionally, research into novel delivery systems is expanding the potential applications of fibrin sealants. The development of spray applicators and other advanced delivery methods allows for precise and targeted application of fibrin sealants, improving their effectiveness in diverse clinical settings. These delivery innovations enable healthcare providers to use fibrin sealants in a broader range of procedures, ensuring optimal performance and outcomes.

The integration of biocompatible and bioactive components into fibrin sealant formulations is another trend impacting the market. Manufacturers are exploring the incorporation of growth factors, antimicrobial agents, and other therapeutic additives into fibrin sealants to enhance their healing properties. These advancements are aimed at improving patient outcomes by promoting tissue regeneration and reducing the risk of infection. As research continues to uncover the benefits of these enhancements, the demand for multifunctional fibrin sealants is expected to grow.

Moreover, the rise of minimally invasive surgical techniques is influencing the fibrin sealants market. As surgeons increasingly adopt less invasive approaches to procedures, the need for effective wound closure solutions that align with these techniques is rising. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, making them a preferred choice in minimally invasive surgeries.

The emphasis on patient safety and regulatory compliance is also driving innovation in the fibrin sealants market. Manufacturers are investing in research and testing to ensure that their products meet the highest safety and efficacy standards. The focus on developing fibrin sealants with proven clinical benefits and safety profiles is essential for gaining acceptance among healthcare providers and regulatory bodies. This commitment to quality and safety is expected to enhance the reputation of fibrin sealants in the medical community.

What Is Driving the Growth in the Fibrin Sealants Market?

The growth in the fibrin sealants market is driven by several key factors, including increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. One of the primary drivers is the growing number of surgical procedures performed globally. As the healthcare industry continues to expand, the demand for effective hemostatic agents and wound closure solutions is increasing. Fibrin sealants provide an effective option for controlling bleeding and promoting healing, making them essential in various surgical specialties.

The rising demand for advanced wound care solutions is another significant factor contributing to market growth. With an increasing prevalence of chronic wounds, pressure ulcers, and surgical site infections, healthcare providers are seeking innovative approaches to enhance wound healing and reduce complications. Fibrin sealants, with their ability to support tissue repair and reduce infection risks, are becoming increasingly popular in wound management. The ongoing emphasis on patient safety and improved clinical outcomes is further driving the demand for effective wound care products.

Additionally, the focus on minimizing postoperative complications and enhancing recovery times is influencing the fibrin sealants market. Healthcare providers are recognizing the benefits of using fibrin sealants in reducing bleeding, promoting healing, and minimizing the need for additional interventions. As hospitals and surgical centers prioritize patient outcomes and efficiency, the adoption of fibrin sealants in surgical practice is expected to grow.

Moreover, advancements in surgical techniques and technology are facilitating the integration of fibrin sealants into routine surgical practice. As minimally invasive procedures gain popularity, the need for effective wound closure solutions that align with these techniques becomes increasingly important. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, contributing to their growing use in various surgical specialties.

Finally, ongoing research and clinical studies investigating the efficacy of fibrin sealants in different applications are driving market growth. As new evidence emerges regarding the benefits of fibrin sealants in various surgical procedures, healthcare providers are likely to incorporate these products into their practice. The expanding body of clinical data supporting the use of fibrin sealants will enhance their acceptance and utilization in the medical community.

In conclusion, the fibrin sealants market is poised for significant growth driven by increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. Technological advancements in product formulations and delivery methods will further enhance the market`s potential. As healthcare providers continue to prioritize patient safety and effective wound management, the demand for fibrin sealants is expected to flourish in the coming years.

Select Competitors (Total 36 Featured) -
  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Fibrin Sealants – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increased Adoption of Fibrin Sealants in Hemostasis and Wound Healing Expands Addressable Market
Surge in Demand for Fibrin Sealants in Minimally Invasive Surgeries Fuels Market Growth
Growing Focus on Fibrin Sealants for Reducing Blood Loss and Postoperative Complications Strengthens Business Case
Surge in Adoption of Fibrin Sealants in Orthopedic and Trauma Surgeries Expands Market Opportunities
Growing Demand for Fibrin Sealants in Dental and Maxillofacial Surgeries Expands Addressable Market
Surge in Adoption of Fibrin Sealants in Plastic and Reconstructive Surgeries Expands Market Opportunities
Technological Advancements in Fibrin Sealants for Enhanced Biocompatibility Propel Market Growth
Growing Use of Fibrin Sealants in Neurosurgery and Spinal Procedures Strengthens Business Case
Rising Adoption of Fibrin Sealants in Emerging Markets with Expanding Healthcare Infrastructure Sets the Stage for Growth
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Cardiovascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Transplant Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 34: World Fibrin Sealants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
CHINA
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
SPAIN
TABLE 119: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 122: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
TABLE 128: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 131: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
AUSTRALIA
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 158: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 161: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
INDIA
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 167: India Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 170: India Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 176: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 179: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
LATIN AMERICA
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 194: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 206: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 209: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
BRAZIL
TABLE 215: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 218: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
MEXICO
TABLE 224: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 227: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
MIDDLE EAST
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 242: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
IRAN
TABLE 254: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 257: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
ISRAEL
TABLE 263: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 266: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 281: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 284: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
AFRICA
Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 299: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2014, 2024 & 2030
TABLE 302: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings